Panelists discuss the process of selecting a treatment plan, including how shared decision-making was approached, the key factors considered in treatment options, how patients can advocate for their preferences, and the process of recommending pembrolizumab plus lenvatinib based on clinical presentation, with a discussion of other regimens that were considered.
Video content above is prompted by the following:
2 Commerce Drive
Cranbury, NJ 08512